A large number of experimental compounds are being developed for the treatment of patients with Alzheimer's disease (AD). As dierent compounds may have dierent eects on CNS function, depending on which neurotransmitters they aect, adequate proยฎling will require the use of several tests. The dicultie
Reliability of flicker threshold measurement in patients with primary degenerative dementia of the Alzheimer's type (PDDAT)
โ Scribed by Dr. S. Curran; J. P. Wattis; I. Hindmarch
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 455 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
โฆ Synopsis
The test-retest and split-half ,reliability of flicker threshold measurement was determined in 23 female and three male patients with primary degenerative dementia of the Alzheimer's type (PDDAT). Patients had a mean age of 81.7 f 6.05 years (range 67-89). Diagnosis of PDDAT was based on DSM-IIIR criteria. The psychophysical method of limits was used to determine the flicker threshold and was the average of four separate measurements.
The split-half reliability was found to be 0.97 and the test-retest reliability 0.941 (bothp < 0.0001). The measurement of flicker thresholds is a quick, easy and reliable technique in patients with PDDAT. Future work will also need to examine the validity and pharmacosensitivity of the measure if it is to be used to assess potentially therapeutic agents for the management of the underlying disease process.
KEY woms-Flicker threshold, primary degenerative dementia of the Alzheimer's type, test-retest and split-half reliability.
๐ SIMILAR VOLUMES
## Aim: To assess the inter-informant reliability, intra-informant reliability and internal consistency of the neo-ffi as a measure of premorbid personality in patients with alzheimer's disease (ad). ## Subjects: One hundred and five persons with nincds-adrda probable ad for the assessment of int
To explore the effect of a non-aerobic movement based activity on cognition in people with Alzheimer's type dementia (AD). Methods: The sample consisted of 27 patients fulfilling the AD ICD-10 diagnostic criteria. The patient sample was randomly divided into two groups: The Exercise Group received 6